Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...
In 2024, the USFDA issued a warning letter to Sun Pharma alleging 'significant violations' of 'current good manufacturing ...
THE Food and Drug Administration (FDA) on Saturday warned the public against non-FDA-approved health and beauty products sold ...
SHANGHAI, Jan 27 (Reuters) - China's medicine regulator has ordered a halt to the import, sale and usage of a drug used to ...
ProdromeNeuro™ and ProdromeGlia™ will now be available in Japan. We've built long-standing and trusted relationships ...
On January 15th, 2026, the Decree amending, adding, and repealing various provisions of the General Health Law (“Amendment”) was published in ...
Regulatory oversight has instead been exercised by the NAFDAC pursuant to its general mandate under the NAFDAC Act (Cap N1, ...
Generative AI in medtech raises questions on safety, validation, and regulatory challenges, explored in MD&M West's "GenMLP" session.
PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) just issued a joint statement outlining 10 “Guiding Principles” ...
There is plenty of opportunity for medtech manufacturers in Asia, but first you need to know how to avoid costly pitfalls.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results